PDX Portal

Model Details

Patient Information for Model: TCH-AML013

Model Contact

Model: TCH-AML013
Model Contact: Michele Redell
Institution: TCH Leukemia PDX Program
Email: mlredell@texaschildrens.org

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML013

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCH-AML013

There are no histology images for this model.

Metastasis Information for Model: TCH-AML013

Patient

PDX

Central Nervous System

Face

Gingiva

Liver

Lymph node

Orbital chloroma

Retinas

Skin

Spleen

Testis

Tongue

Patient Treatment Information for Model: TCH-AML013

Event Id	Treatment	Treatment Setting	Age at Start	Duration	Clinical Response
10	ADE10	De Novo	12.91	1Unknown	Remission
20	ADE8	Remission	13.0	1Unknown	Relapse
30	cytarabine/etoposide	Relapse	13.13	1Unknown	Refractory
40	cytarabine/asparaginase	Remission	13.22	1Unknown	Remission
55	FLAG	Relapse	13.41	1Unknown	Refractory
65	TVTC	Refractory	13.45	1Unknown	Refractory
75	Decitabine	Pallative	13.55	1Unknown